Intellectual Property

Threading the biosimilar needle

Thursday, February 11, 2016 @ 7:00 PM | By Nikolas Purcell and Geoffrey Mowatt

Biosimilars, otherwise known as subsequent entry biologics or “SEBs” in Canada, are a rapidly emerging trend in health care.

Biosimilars present novel and intriguing legal issues that are quickly rising to...

To view the full article, Click Here to Subscribe
or sign up for a 14-day FREE Trial

Already a subscriber? Click here to sign in

Featured

Roomies and Zoomies: Pandemic has sparked new terms, some innovation in law school teaching

Latest

Supreme Court of Canada Supreme Court of Canada won’t hear s. 12 Charter attack on regulatory mandatory minimum fines

Civil Litigation Paliare Roland team grows by three associates

Tax Gowling adds tax partner in Calgary

B.C. Court of Appeal Story image

Organizations with easements across reserve land should look at B.C. appeal decision, lawyer says

Labour & Employment Story image

‘Just cause’ termination clause upheld but decision ripe for appeal